1987
DOI: 10.1073/pnas.84.4.1055
|View full text |Cite
|
Sign up to set email alerts
|

Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human.

Abstract: Skin fibroblasts might be considered suitable recipients for therapeutic genes to cure several human genetic diseases; however, these cells are resistant to gene transfer by most methods. We have studied the ability of retroviral vectors to transfer genes into normal human diploid skin fibroblasts. Retroviruses carrying genes for neomycin or hygromycin B resistance conferred drug resistance to greater than 50% of the human fibroblasts after a single exposure to virus-containing medium. This represents at least… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
30
0
1

Year Published

1991
1991
2009
2009

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 134 publications
(31 citation statements)
references
References 32 publications
0
30
0
1
Order By: Relevance
“…Knockout and wild-type control keratinocytes were infected 2 days after plating with a high titer helper-free recombinant retrovirus based on the LXCN vector (Palmer et al 1987) and transducing the v-Ha-ras oncogene (Dotto et al 1985). At 6 days after infection, cells were collected by trypsinization, counted, and injected subcutaneoulsy into nude mice at the indicated concentrations.…”
Section: Tumorigenicity Assaysmentioning
confidence: 99%
“…Knockout and wild-type control keratinocytes were infected 2 days after plating with a high titer helper-free recombinant retrovirus based on the LXCN vector (Palmer et al 1987) and transducing the v-Ha-ras oncogene (Dotto et al 1985). At 6 days after infection, cells were collected by trypsinization, counted, and injected subcutaneoulsy into nude mice at the indicated concentrations.…”
Section: Tumorigenicity Assaysmentioning
confidence: 99%
“…49 We have previously estimated the number of LNSA-transduced patient fibroblasts necessary to provide treatment at 4 × 10 8 , based on data from red cell therapy. 27 As LNFnA and LNSA vectors express similar amounts of ADA in transduced fibroblasts, then 4 × 10 8 cells expressing ADA from the fibronectin promoter would provide enzyme to metabolize the cytotoxic ADA substrates deoxyadenosine and adenosine that accumulate in ADA deficiency.…”
Section: Discussionmentioning
confidence: 99%
“…27 As LNFnA and LNSA vectors express similar amounts of ADA in transduced fibroblasts, then 4 × 10 8 cells expressing ADA from the fibronectin promoter would provide enzyme to metabolize the cytotoxic ADA substrates deoxyadenosine and adenosine that accumulate in ADA deficiency. 49,50 Transfer of this number of cells is feasible using skin equivalent grafts. It is likely that the calculated number is an overestimate as genetically modified cells continually produce ADA, whereas transfused red cells have a 20-to 30-day half-life with diminishing therapeutic ADA activity.…”
Section: Discussionmentioning
confidence: 99%
“…The LHL vector carries the hygromycin B resistance marker driven by the Moloney murine leukaemia virus LTR and contains normal splice donor and acceptors. 35 The ecotropic receptor gene on the vector pJET (kindly supplied by JM Cunningham) was used to construct a vector for high-level expression of the ecotropic receptor with a selectable marker gene. This vector, pMETbsr, was generated using the plasmids pMSG and pSV2bsr, which contain the MMTVLTR promoter and a blasticidin selectable marker respectively.…”
Section: Infection Of V79 Cells By Lhl Ecotropic Virusesmentioning
confidence: 99%